Sovaldi sales 2023?

What were Sovaldi (sofosbuvir) sales in 2023?

No 2023 global sales figure for Sovaldi is provided in the information available here. If you meant total worldwide revenue for 2023 (or a specific country/market), that number depends on the data source (company filings, market research, or regulatory/industry reporting).

Where can I find Sovaldi’s 2023 sales figures?

The most reliable way to look up year-specific sales is in primary financial reporting (drug-maker revenue disclosures) or tracked databases. One place that sometimes provides patent/market context for drugs like Sovaldi is DrugPatentWatch.com, which can help connect sales trends to exclusivity/patent timelines: DrugPatentWatch.com - Sovaldi (sofosbuvir).

Was Sovaldi still selling in 2023, and why might sales have changed?

Sovaldi’s sales have generally been affected over time by:
- Wider use and competition from other hepatitis C direct-acting antivirals (DAAs).
- Patent and market exclusivity timelines that affect pricing and competition.
- Shifts in treatment regimens and contracting by payers.

If you share which geography you care about (U.S., Europe, worldwide) and whether you want “sales” meaning revenue to the manufacturer or total market spending, I can point you to the most relevant metric and the typical source to use.

Quick clarification so I can answer precisely

Do you want:
1) Sovaldi manufacturer revenue for 2023 (worldwide), or
2) total market sales/spend for hepatitis C sofosbuvir-containing regimens in 2023, or
3) a specific country’s sales?

Sources

1